launch excellence

Market Access

Pharma’s post-pandemic launch performance problem: what’s th...

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth.

Partner Content

How digital connectivity is driving faster patient access

Partner Content

Future focus: 3 tools for launching fast in the face of unce...

Imagine you had a crystal ball which allowed you to see into the future and understand exactly how your life science launch would pan out.

Views & Analysis

Three pillars of post-pandemic launch excellence

IQVIA's Sarah Rickwood

R&D

The new global digital health paradigm in life sciences

Digital transformation has long been a priority for all life science companies and it has been made even more pressing by the current health emergency caused by COVID-19.

Market Access

Achieving launch excellence in orphan medicines

New rare disease treatments face a complex market access landscape that presents fundamental challenges for pharmaceutical companies seeking to achieve launch excellence.